Episode Summary
A/Prof Craig Underhill, Prof Sabe Sabesan and patient advocate Alexandra Golledge discuss how TeleTrials bring new therapies to patients sooner. New frameworks are increasing clinical trial participation and co ordination between trial and satellite centres is improving. Imaging, blood tests and examinations can be done at a local level, without extensive travel that was deemed necessary in the past. Barriers and facilitators and a unique insight into the patient benefits are discussed between Alexandra Golledge, Prof Sabe Sabesan and A/Prof Craig Underhill. Incentive funding and harmonising governance requirements for TeleTrials in Australia will help solve many of these issues and continue to transform the way trials are managed. The benefits for patients and their families are clear and positively impact the future of trials in Australia.
Resources:
- https://wiki.cancer.org.au/australia/COSA:Teleoncology
- https://www.digitalhealth.gov.au/healthcare-providers/initiatives-and-programs/telehealth
- https://thoraciconcology.org.au/teletrials/
Supported by Takeda
Disclaimer: The opinions, beliefs and viewpoints expressed by the various authors and participants contained in this message do not necessarily reflect the opinions, beliefs and viewpoints of TOGA or official policies of TOGA. Dosage & administration of any treatments mentioned during TOGA medical education may differ between Regions. Please refer to your local prescribing information for further details.
Show Hosts
This episode’s host are:
- Alexandra Golledge, patient advocate, teletrials participant and lung cancer survivor
- Prof Sabe Sabesan, Medical Oncologist, ICON Cancer Centre Townsville; Co-Chair, Australian Teletrial Program and initial teletrials pilot 2017-2020
- A/Prof Craig Underhill, Medical Oncologist, Border Medical Oncology and Haematology Albury/Wodonga
